XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Compensation Expense
Stock-based compensation expense relating to Restricted Series D Preferred Stock is allocated as follows (in thousands):

Three Months Ended September 30,
Nine Months Ended September 30,
Three and Nine Months Ended September 30,
202020202019
Research and development
$11 $39 $— 
Sales and marketing
17 — 
General and administrative
10 27 — 
$28 $83 $— 
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Options Granted, Exercised, Expired and Forfeited
A summary of stock options expired and forfeited under our plans and options outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019 is presented below:
Outstanding and Exerciseable
Number of Options
Weighted Average Exercise Price
Options outstanding, December 31, 2018118,003 $19.90 
Exchanged for Oblong Industries stock options107,845 4.92 
Expired(440)16.48
Forfeited(10,063)23.20
Options outstanding, December 31, 2019215,345 12.27 
Expired(107,845)4.92 
Options outstanding and exercisable, September 30, 2020107,500 $19.64 
Shares Outstanding and Exercisable, By Exercise Price Range
Additional information as of September 30, 2020 is as follows:

 Outstanding and Exercisable
Range of priceNumber
of Options
Weighted
Average
Remaining
Contractual
Life (In Years)
Weighted
Average
Exercise
Price
$0.00 – $10.00
2,500 2.70$9.00 
$10.01 – $20.00
97,500 2.3119.32 
$20.01 – $30.00
2,500 1.6821.80 
$30.01 – $40.00
5,000 1.4530.20 
107,500 2.26$19.64 
Restricted stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Share Activity
A summary of restricted stock granted, vested and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below:
Restricted Shares
Weighted Average Grant Date Price
Unvested restricted stock outstanding, December 31, 201811,320 $14.88 
Granted— — 
Vested(1,372)15.72 
Forfeited(9,321)14.70 
Unvested restricted stock outstanding, December 31, 201962715.80 
Unvested restricted stock outstanding, September 30, 2020627 $15.80 
Schedule of Compensation Expense
Stock-based compensation expense relating to restricted stock awards is allocated as follows (in thousands):
Three Months EndedNine Months Ended
September 30,September 30,
2020201920202019
General and administrative— — — 
$— $— $— $
RSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Nonvested Share Activity
A summary of restricted stock units (“RSUs”) granted, vested, forfeited and unvested outstanding as of, and changes made during, the nine months ended September 30, 2020 and the year ended December 31, 2019, is presented below:
Restricted Stock Units
Weighted Average Grant Price
Unvested restricted stock units outstanding, December 31, 2018503,518 $1.94 
Granted55,479 1.30 
Vested(114,505)3.05 
Forfeited(421,158)1.54 
Unvested restricted stock units outstanding, December 31, 201923,334 2.20 
Vested(23,334)2.20 
Unvested restricted stock units outstanding, September 30, 2020— $— 
Schedule of Compensation Expense
Stock-based compensation expense relating to restricted stock units is allocated as follows (in thousands):

Three Months EndedNine Months Ended
September 30,September 30,
2020201920202019
Cost of revenue$— $$— $10 
Research and development— — 11 
Sales and marketing— — — — 
General and administrative— 10 43 
$— $14 $$64